ALTACE 1.25 mg MP
Generic Name: ramipril
Pill imprint ALTACE 1.25 mg MP has been identified as Altace 1.25 mg.
Altace is used in the treatment of high blood pressure; heart failure; diabetic kidney disease; heart attack; left ventricular dysfunction and belongs to the drug class angiotensin converting enzyme inhibitors. There is positive evidence of human fetal risk during pregnancy.
Altace 1.25 mg is not subject to the Controlled Substances Act.
See also related documents.
Altace Images
- Generic Name:
- ramipril
- Imprint:
-
ALTACE 1.25 mg
MP - Strength:
- 1.25 mg
- Color:
- Yellow
- Size:
- 4.00 mm
- Shape:
- Capsule-shape
- Availability:
- Prescription only
- Inactive Ingredients:
- pregelatinized starch
gelatin
titanium dioxide
ferric oxide yellow
- Drug Class:
- Angiotensin converting enzyme inhibitors
- Pregnancy Category:
- D - Positive evidence of risk
- CSA Schedule:
- N - Not a controlled drug
- Manufacturer:
- Monarch Pharmaceuticals, Inc.
- National Drug Code (NDC):
- 61570-0110
Advertisement
More Altace resources
- Altace
- Altace (Wolters Kluwer)
- Altace Capsules (Wolters Kluwer)
- Altace (Cerner Multum)
- Altace (Micromedex) - Includes Dosage Information
- Altace (AHFS DI)
- Altace (FDA)
- Altace Tablets (FDA)
Search Again
